Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease
Marie Czech,Sophia Schneider,Nina Peltokangas,Nadia El Khawanky,Sakhila Ghimire,Geoffroy Andrieux,Jan Hülsdünker,Máté Krausz,Michele Proietti,Lukas M Braun,Tamina Rückert,Marlene Langenbach,Dominik Schmidt,Ina Martin,Valentin Wenger,Enrique de Vega,Eileen Haring,Mohsen Pourjam,Dietmar Pfeifer,Annette Schmitt-Graeff,Bodo Grimbacher,Konrad Aumann,Brigitte Kircher,Herbert Tilg,Manuela Raffatellu,Erik Thiele Orberg,Georg Häcker,Justus Duyster,Natalie Köhler,Ernst Holler,David Nachbaur,Melanie Boerries,Romana R Gerner,Dominic Grün,Robert Zeiser,Lukas M. Braun,Romana R. Gerner
DOI: https://doi.org/10.1126/scitranslmed.adi1501
IF: 17.1
2024-02-23
Science Translational Medicine
Abstract:Acute graft-versus-host disease (aGVHD) is a life-threatening complication of allogeneic hematopoietic cell transplantation (allo-HCT), for which therapeutic options are limited. Strategies to promote intestinal tissue tolerance during aGVHD may improve patient outcomes. Using single-cell RNA sequencing, we identified a lipocalin-2 (LCN2)–expressing neutrophil population in mice with intestinal aGVHD. Transfer of LCN2-overexpressing neutrophils or treatment with recombinant LCN2 reduced aGVHD severity, whereas the lack of epithelial or hematopoietic LCN2 enhanced aGVHD severity and caused microbiome alterations. Mechanistically, LCN2 induced insulin-like growth factor 1 receptor (IGF-1R) signaling in macrophages through the LCN2 receptor SLC22A17, which increased interleukin-10 (IL-10) production and reduced major histocompatibility complex class II (MHCII) expression. Transfer of LCN2-pretreated macrophages reduced aGVHD severity but did not reduce graft-versus-leukemia effects. Furthermore, LCN2 expression correlated with IL-10 expression in intestinal biopsies in multiple cohorts of patients with aGVHD, and LCN2 induced IGF-1R signaling in human macrophages. Collectively, we identified a LCN2-expressing intestinal neutrophil population that reduced aGVHD severity by decreasing MHCII expression and increasing IL-10 production in macrophages. This work provides the foundation for administration of LCN2 as a therapeutic approach for aGVHD.
cell biology,medicine, research & experimental